Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 3/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.31 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 3/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31357995 | 0.78 | NPC1 (0.37) | DGAT1NPC1 | |
| SCHEMBL24096893 | 0.77 | DGAT1 (0.41) | DGAT1NPC1 | |
| SCHEMBL25770427 | 0.77 | ESR1 (0.40) | DGAT1NPC1 | |
| SCHEMBL31056355 | 0.76 | NPC1 (0.34) | DGAT1NPC1 | |
| SCHEMBL31056563 | 0.74 | NPC1 (0.33) | DGAT1NPC1 | |
| SCHEMBL31055904 | 0.74 | NPC1 (0.36) | BRD4DGAT1NPC1 | |
| SCHEMBL31358117 | 0.73 | NPC1 (0.37) | DGAT1NPC1SMN1; SMN2 | |
| SCHEMBL31056473 | 0.72 | NPC1 (0.32) | DGAT1NPC1 | |
| SCHEMBL16023365 | 0.71 | NPC1 (0.42) | DGAT1NPC1SMN1; SMN2 | |
| SCHEMBL30509474 | 0.69 | L3MBTL1 (0.37) | BRD4DGAT1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024259241-A1 | 5-HT2A RECEPTOR MODULATORS AND METHODS OF USE THEREOF | Transneural Therapeutics, Inc. (US) | 2024-12-19 | — | — | WO | disclosed |